Skip to main content

Advertisement

Log in

Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics

  • Review
  • Published:
Biologia Aims and scope Submit manuscript

Abstract

Type II diabetes is a metabolic disorder characterized by hyperglycemia arising from defective insulin signaling. Several synthetic drugs are being used for diabetes treatment, but they have adverse effects. So as an alternative approach, compounds from plants with lesser/no side effects and comparatively cheaper are gaining momentum. Terpenes comprise a class of diversified phytochemicals, which have beneficial effects and important functions in plants. They have shown a series of biological properties that health­promoting conduct in humans. Besides, a lot of terpenes have also been reported to be much less toxic as compared to synthetic compounds. Diabetic people could be benefited from terpenes obtained either from the diet or from plant-derived herbal medicines. Due to the natural origin of terpenes, they are supposed to be a safe and promising agent in eliminating the causes and effects of diabetes. This paper reviews the research reports of terpenes as their antidiabetic potential, mechanistic action, preclinical profile, shortcomings, and prospect in the effective management of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ACC:

Acetyl-CoA carboxylase

ACE:

Angiotensin converting enzyme

AGEs:

Advanced glycation end products

AMPK:

AMP­ activated protein kinase

AR:

Aldose reductase

DAA:

Dehyroabietic acid

DM:

Diabetes mellitus

DPP IV:

Dipeptidyl peptidase IV

DPPH:

2,2-diphenyl-1-picryhydrazyl

ER:

Endoplasmic reticulum

GADA:

Glutamic Acid Decarboxylose

GLP:

Glucagon like peptide

GSP:

Glycosylated serum protein

HbA1c:

Haemoglobin A1c

IA2A:

Insulinoma associated autoantigen 2

IDDM:

Insulin­dependent diabetes mellitus

IR:

Insulin receptor

IRE1:

Inositol requiring enzyme 1

IRS:

Insulin receptor substrate

LC-MS:

liquid chromatography-mass spectrometry

MAPK:

Mitogen-activated protein kinase

MDA:

Malondialdehyde

NF-kB:

Nuclear factor kappa-B

NIDDM:

Non­insulin­dependent diabetes mellitus

NLC:

Nano-structured lipid carriers

NLRP3:

Nod like receptor family pyrin domain containing 3

Nrf2:

Nuclear factor erythroid 2-related factor

OGTT:

Oral glucose tolerance test

PL:

Pancreatic lipase

PPAR:

Peroxisome proliferator activator receptor

PTP:

Protein tyrosine phosphatase

ROS:

Reactive oxygen species

SIRT1:

Silent mating type information regulation 2 homolog 1 overexpression

SLN:

Solid lipid nanoparticles

SOD:

Superoxide dismutase

STZ :

Streptozotocin

STZ-NA:

Streptozotocin-Nicotinamide

TG :

Triglyceride

TNF α:

Tumor necrosis factor­-α

TTA:

Total triterpene acid

References

Download references

Acknowledgements

The authors are thankful to the GGU, Bilaspur (India), and NIT, Raipur (India) for support and facility. Financial assistance to SKP as SRF for Ph.D. from University Grants Commission (UGC), New Delhi, India is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Renu Bhatt or Awanish Kumar.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panigrahy, S.K., Bhatt, R. & Kumar, A. Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics. Biologia 76, 241–254 (2021). https://doi.org/10.2478/s11756-020-00575-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11756-020-00575-y

Keywords

Navigation